» Articles » PMID: 31490367

The Association Between CKD-associated Pruritus and Quality of Life in Patients Undergoing Hemodialysis in Pakistan: A STROBE Complaint Cross-sectional Study

Overview
Specialty General Medicine
Date 2019 Sep 7
PMID 31490367
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic kidney disease (CKD)-associated pruritus is one of the most common symptoms found in patients who undergo dialysis for CKD, leading to a compromised quality of life. This study aimed to investigate the association between CKD-associated pruritus and the quality of life in patients undergoing hemodialysis in Pakistan.A cross-sectional multicenter study was carried out from July 2016 to April 2017 in 2 tertiary care hospitals in Pakistan. Patients aged 18 years and above of both genders, undergoing hemodialysis, understood the Urdu language, and were willing to participate; were included.Of 354 recruited patients with a response rate of 100%, majority (66.1%) of the patients were males. The median (intra-quartile range [IQR]) age of patients was 42.0 [34.0-50.0] years. The prevalence of pruritus was 74%. The median [IQR] score for pruritus was 10.0 (out of possible 25) [8.0-12.0]. Multivariate linear regression revealed a statistically significant association between CKD-associated pruritus with age of patients (β = 0.031; 95% confidence interval [CI] = 0.002-0.061; P = .038), duration of CKD (β = -0.013; 95% CI = -0.023 --0.003; P = .014) and quality of life (β= -0.949; 95% CI = -1.450; -0.449). The median [IQR] score for health-related quality of life was 52.00 [43.00-58.00].Prevalence of CKD-associated pruritus was reported to be 74% and it negatively affected the patient's quality of life. Patients with moderate to severe CKD-associated pruritus have poor quality of life. With an increase in intensity of pruritus, the QOL score decreased among the patients undergoing hemodialysis.

Citing Articles

Chronic kidney disease-associated pruritus and patient-centred outcomes: a systematic review.

Wang T, Goh J, Seth S, Do L, Tesfaye W, Sud K J Nephrol. 2025; .

PMID: 40000587 DOI: 10.1007/s40620-025-02221-9.


Impact of pharmacist-led intervention for reducing drug-related problems and improving quality of life among chronic kidney disease patients: A randomized controlled trial.

Zafar R, Rehman I, Shah Y, Ming L, Goh K, Suleiman A PLoS One. 2025; 20(2):e0317734.

PMID: 39899613 PMC: 11790119. DOI: 10.1371/journal.pone.0317734.


The relationship between fatigue, pruritus, and thirst distress with quality of life among patients receiving hemodialysis: a mediator model to test concept of treatment adherence.

Sharif-Nia H, Maroco J, Sivarajan Froelicher E, Barzegari S, Sadeghi N, Fatehi R Sci Rep. 2024; 14(1):9981.

PMID: 38693146 PMC: 11063047. DOI: 10.1038/s41598-024-60679-2.


Can Pharmacists' Counseling Improve the Use of Inhalers and Quality of Life? A Prospective "Pre" and "Post" Education Analysis in Mardan, Pakistan.

Gul S, Rehman I, Goh K, Ali Z, Rahman A, Khalil A J Asthma Allergy. 2023; 16:679-687.

PMID: 37435420 PMC: 10332412. DOI: 10.2147/JAA.S405943.


Assessment of Health-Related Quality of Life, Medication Adherence, and Prevalence of Depression in Kidney Failure Patients.

Butt M, Ong S, Butt F, Sajjad A, Rasool M, Imran I Int J Environ Res Public Health. 2022; 19(22).

PMID: 36429988 PMC: 9690334. DOI: 10.3390/ijerph192215266.